These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication. Lin JC; De Clercq E; Pagano JS Antimicrob Agents Chemother; 1991 Nov; 35(11):2440-3. PubMed ID: 1666500 [TBL] [Abstract][Full Text] [Related]
23. Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication. Colby BM; Shaw JE; Elion GB; Pagano JS J Virol; 1980 May; 34(2):560-8. PubMed ID: 6246281 [TBL] [Abstract][Full Text] [Related]
24. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on replication of Epstein-Barr virus in human lymphoblastoid cell lines. Lin JC; Smith MC; Choi EI; De Clercq E; Verbruggen A; Pagano JS Antiviral Res; 1985; Suppl 1():121-6. PubMed ID: 3002251 [TBL] [Abstract][Full Text] [Related]
25. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro. Crance JM; Lévêque F; Biziagos E; van Cuyck-Gandré H; Jouan A; Deloince R Antiviral Res; 1994 Jan; 23(1):63-76. PubMed ID: 8141593 [TBL] [Abstract][Full Text] [Related]
26. Enhancement of replication of Epstein-Barr virus DNA in human lymphoblastoid cell lines by N-methyl-N'-nitro-N-nitrosoguanidine. Lin JC; Smith MC; Pagano JS Carcinogenesis; 1983; 4(2):185-8. PubMed ID: 6297823 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole. Zacny VL; Gershburg E; Davis MG; Biron KK; Pagano JS J Virol; 1999 Sep; 73(9):7271-7. PubMed ID: 10438815 [TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of cycloSaligenyl-nucleoside monophosphates (cycloSal-NMP) of acyclic nucleoside analogues on HSV-1 and EBV. Meerbach A; Klöcking R; Meier C; Lomp A; Helbig B; Wutzler P Antiviral Res; 2000 Jan; 45(1):69-77. PubMed ID: 10774591 [TBL] [Abstract][Full Text] [Related]
29. Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication. Diabata M; Enzinger EM; Monroe JE; Kilkuskie RE; Field AK; Mulder C Antiviral Res; 1996 Mar; 29(2-3):243-60. PubMed ID: 8739603 [TBL] [Abstract][Full Text] [Related]
30. Comparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replication. Lin JC; Machida H Antimicrob Agents Chemother; 1988 Jul; 32(7):1068-72. PubMed ID: 2847639 [TBL] [Abstract][Full Text] [Related]
31. Effects of 12-O-tetradecanoyl-phorbol-13-acetate on cell proliferation and Epstein-Barr virus DNA replication. Lin JC; Smith MC; Pagano JS Virology; 1982 Feb; 117(1):186-94. PubMed ID: 6278735 [No Abstract] [Full Text] [Related]
32. Antagonistic action of retinoic acid against teleocidin and 12-O-tetradecanoyl-phorbol-13-acetate on activation of Epstein-Barr virus genomes. Lin JC; Smith MC Carcinogenesis; 1984 Apr; 5(4):483-7. PubMed ID: 6323048 [TBL] [Abstract][Full Text] [Related]
33. Some nucleoside analogs with anti-human immunodeficiency virus activity inhibit replication of Epstein-Barr virus. Mar EC; Chu CK; Lin JC Antiviral Res; 1995 Sep; 28(1):1-11. PubMed ID: 8585756 [TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus: inhibition of replication by three new drugs. Lin JC; Smith MC; Cheng YC; Pagano JS Science; 1983 Aug; 221(4610):578-9. PubMed ID: 6306771 [TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication. Meerbach A; Holý A; Wutzler P; De Clercq E; Neyts J Antivir Chem Chemother; 1998 May; 9(3):275-82. PubMed ID: 9875407 [TBL] [Abstract][Full Text] [Related]
36. Metabolic activation of 9([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human lymphoblastoid cell lines infected with Epstein-Barr virus. Lin JC; Nelson DJ; Lambe CU; Choi EI J Virol; 1986 Nov; 60(2):569-73. PubMed ID: 3021990 [TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94. Gershburg E; Pagano JS J Virol; 2002 Feb; 76(3):998-1003. PubMed ID: 11773375 [TBL] [Abstract][Full Text] [Related]
39. Replication of latent Epstein-Barr virus genomes in Raji cells. Adams A J Virol; 1987 May; 61(5):1743-6. PubMed ID: 3033303 [TBL] [Abstract][Full Text] [Related]
40. A reporter system for Epstein-Barr virus (EBV) lytic replication: anti-EBV activity of the broad anti-herpesviral drug artesunate. Auerochs S; Korn K; Marschall M J Virol Methods; 2011 May; 173(2):334-9. PubMed ID: 21396962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]